BL Pharmtech Corp.
Financials
Valuation Metrics
BL Pharmtech Corp.'s Market Cap is ₩649B. At end of 2025 it was ₩153B. Ranked #1555 of 2,436 in KR market (top 64%), #907 of 1,649 on KOSDAQ (top 55%), #33 of 57 in Household & Personal Products (top 58%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 64.90B KRW | KR#1,555/2,436 Sec#33/57 |
| Revenue | 5.04B KRW | KR#2,343/2,436 Sec#56/57 |
| Net Income | -15.20B KRW | KR—/2,436 Sec—/57 |
| Total Assets | 18.74B KRW | KR#2,370/2,436 Sec#56/57 |
| Net Assets | 10.33B KRW | KR#2,362/2,436 Sec#57/57 |
| Employees | 16 | KR#2,243/2,436 Sec#56/57 |
| Value | ||
| P/B | 6.28x | KR#2,281/2,436 Sec#54/57 |
| P/S | 12.89x | KR#2,298/2,436 Sec#56/57 |
| Profitability | ||
| ROE | -147.17% | KR#2,363/2,436 Sec#57/57 |
| ROA | -81.10% | KR#2,377/2,436 Sec#57/57 |
| Op. Margin | -43.10% | KR#2,222/2,436 Sec#54/57 |
| Revenue Growth | -49.23% | KR#2,277/2,436 Sec#54/57 |
| Financial Health | ||
| Debt Ratio | 81.47% | KR#267/2,436 Sec#8/57 |
| Total Debt | 3.05B KRW | KR#1,854/2,436 Sec#43/57 |
| Cash | 6.65B KRW | KR#1,881/2,436 Sec#39/57 |
| Current Ratio | 1.23x | KR#1,549/2,436 Sec#36/57 |
| Performance | ||
| 1Y Return | 193.93% | KR#50/2,436 Sec#1/57 |
| 1M Return | -49.40% | KR#2,424/2,436 Sec#57/57 |
| From 52W High | -71.47% | KR#2,182/2,436 Sec#52/57 |
| 1Y MDD | -76.39% | KR#2,199/2,436 Sec#52/57 |
| Trading | ||
| Volume | 613,114 shares | KR#228/2,436 Sec#3/57 |
| Foreign Own. | 5.69% | KR—/2,436 Sec—/57 |
| Per Share | ||
| EPS | -566 KRW | KR—/2,436 Sec—/57 |
| BPS | 369 KRW | KR#2,413/2,436 Sec#56/57 |
Company Info
BL Pharmtech, established in 1995 and listed on KOSDAQ in 2002, is a specialized healthcare distribution company. It distributes health functional foods and general foods, and manufactures and sells in-vitro diagnostic medical devices, owning brands NFP, Boidang, and ramen brand Mister Min. Leveraging 30 years of distribution experience, the company has built extensive online and offline distribution networks. BL Pharmtech is diversifying its healthcare operations by entering the European ready-to-eat food market and expanding its diagnostic kit business. It is headquartered in Gyeonggi-do, Yongin-si.